Possible Involvement of Minor Lysophospholipids in the Increase in Plasma Lysophosphatidic Acid in Acute Coronary Syndrome | Zendy

Makoto Kurano | Zendy; Akiko Suzuki | Zendy; Asuka Inoue | Zendy; Yasunori Tokuhara | Zendy; Kuniyuki Kano | Zendy; Hirotaka Matsumoto | Zendy; Koji Igarashi | Zendy; Ryunosuke Ohkawa | Zendy; Kazuhiro Nakamura | Zendy; Tomotaka Dohi | Zendy; Katsumi Miyauchi | Zendy; Hiroyuki Daida | Zendy; Kazuhisa Tsukamoto | Zendy; Hitoshi Ikeda | Zendy; Junken Aoki | Zendy; Yutaka Yatomi | Zendy

Open Access

Possible Involvement of Minor Lysophospholipids in the Increase in Plasma Lysophosphatidic Acid in Acute Coronary Syndrome

Author(s) -

Makoto Kurano,

Akiko Suzuki,

Asuka Inoue,

Yasunori Tokuhara,

Kuniyuki Kano,

Hirotaka Matsumoto,

Koji Igarashi,

Ryunosuke Ohkawa,

Kazuhiro Nakamura,

Tomotaka Dohi,

Katsumi Miyauchi,

Hiroyuki Daida,

Kazuhisa Tsukamoto,

Hitoshi Ikeda,

Junken Aoki,

Yutaka Yatomi

Publication year - 2014

Publication title -

arteriosclerosis thrombosis and vascular biology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.007

H-Index - 270

eISSN - 1524-4636

pISSN - 1079-5642

DOI - 10.1161/atvbaha.114.304748

Subject(s) - lysophosphatidic acid , acute coronary syndrome , cardiology , inflammation , medicine , chemistry , myocardial infarction , receptor

Lysophosphatidic acids (LPA) have important roles in the field of vascular biology and are derived mainly from lysophosphatidylcholine via autotaxin. However, in our previous study, only the plasma LPA levels, and not the serum autotaxin levels, increased in patients with acute coronary syndrome (ACS). The aim of this study was to elucidate the pathway by which LPA is increased in patients with ACS.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research